ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes

January 11, 1985

Federal Regs Prohibit RFP Budget Releases

February 21, 1975

In Brief: John Mendelson To Succeed LaMaistre As President, M.D Anderson Cancer Center

May 17, 1996

Oncology Nursing Foundation Offers Research Fellowship, Clinical Scholar Award

September 29, 1995

In Brief: Kennedy To Hold Hearing on Mammography Reimbursement, Waxman On Reauthrization

January 15, 1988